We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 137% below its sector, cheaper than its peers on earnings.
CKD Bio Corp., a South Korean company founded in 1941 and headquartered in Seoul, specializes in the production and distribution of pharmaceutical active ingredients (APIs). Their manufacturing processes leverage diverse technologies, including fermentation, chemical synthesis, and biotechnology. The company's extensive portfolio of APIs targets a broad spectrum of therapeutic applications, encompassing antibiotics, beta-lactamase inhibitors, immunosuppressants, oncology treatments, anti-obesity medications, dry eye remedies, antiviral and antituberculosis agents, antihyperlipidemics, and probiotics. Beyond its core manufacturing, CKD Bio Corp. also provides contract research, development, and manufacturing (CRDMO) services for APIs, pharmaceutical intermediates, and probiotic formulations. The company actively exports its products, establishing a global reach.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 063160.KS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
